Why it Matters

The Cardiac PET Industry Coalition registered as a new client with Polsinelli PC on Monday, June 15, 2026. The registration signals a coordinated push to shape policy around cardiac positron emission tomography technology and related healthcare matters.

The Cardiac PET lobbying effort represents a new player in the medical device lobbying space focused specifically on cardiac imaging technology. By engaging a major law and lobbying firm, the Coalition is positioning itself to influence healthcare policy decisions that could affect reimbursement, regulatory approval, and market access for cardiac PET imaging services. The move suggests the organization believes federal action on health issues warrants direct engagement with Congress and relevant agencies.

The Coalition's decision to hire Polsinelli PC indicates they are escalating their advocacy strategy. The choice of a full-service firm with established relationships in healthcare policy suggests they are serious about sustained engagement on their core issues.

The Big Picture

The Cardiac PET Industry Coalition's lobbying disclosure filing shows the organization is focusing on health issues broadly. Sylvia Kornegay, a Senior Policy Adviser at Polsinelli PC, is listed as the primary lobbyist representing the Coalition. The Cardiac PET lobbying registration covers health issues broadly, without specifying particular legislation or regulatory matters in the initial filing. The cardiac imaging market has faced ongoing pressure regarding reimbursement rates and coverage decisions from Medicare and private insurers, and healthcare policy remains a central focus in Congress, with ongoing discussions about drug pricing, healthcare costs, and medical technology access.

The Bottom Line

The Cardiac PET Industry Coalition's decision to register with Polsinelli PC marks a strategic shift toward direct federal advocacy on health issues. The Coalition is now positioned to engage Congress and federal agencies on matters affecting cardiac PET technology and related healthcare policy.

Access the Legis1 platform for comprehensive political news, data, and insights.

Spot something wrong? Report an issue with this article